This study provides a comprehensive overview of the commercial market for lung, breast and colorectal cancer medicines responding to both cytotoxic and hormonal therapies. Researched countries are Mexico, Brazil, and Argentina. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, major market drivers and restraints, market shares by revenue and commercial forecasts from 2005-2010.
Market Introduction and Executive Summary
- Executive Summary
- Market Introduction and History
- Commercial Market Size and Forecasts
- Market Engineering Measurements
Market Measurements
- Market Profile and Measurements
- Market Drivers
- Market Restraints
- Industry Challenges
Oncology Products for Lung Cancer
- Product Measurements
- Product Pricing Analysis
- Product Distribution Analysis
- Drug Pipeline
- Competitive Measurements
- Market Share Analysis
Oncology Products for Breast Cancer
- Product Measurements
- Product Pricing Analysis
- Product Distribution Analysis
- Drug Pipeline
- Competitive Measurements
- Market Share Analysis
Oncology Products for Colorectal Cancer
- Product Measurements
- Product Pricing Analysis
- Product Distribution Analysis
- Drug Pipeline
- Competitive Measurements
- Market Share Analysis
Market Measurements
Oncology Products for Lung Cancer
Oncology Products for Breast Cancer
Oncology Products for Colorectal Cancer
- Market Profile and Measurements
- Market Drivers
- Market Restraints
- Industry Challenges
Market Measurements
Oncology Products for Lung Cancer
Oncology Products for Breast Cancer
Oncology Products for Colorectal Cancer
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
This study provides a comprehensive overview of the commercial market for lung, breast and colorectal cancer medicines responding to both cytotoxic and hormonal therapies. Researched countries are Mexico, Brazil, and Argentina. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, major market drivers and restraints, market shares by revenue and commercial forecasts from 2005-2010.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | FA2B-01-00-00-00 |
| Is Prebook | No |
Latin American Oncology Therapeutics Markets
Latin American Oncology Therapeutics Markets
RELEASE DATE
10-Jan-2007
10-Jan-2007
REGION
Global
Global
Deliverable Type
Market Research
Market Research
Research Code: FA2B-01-00-00-00
SKU: HC02404-GL-MR_16526
$4,950.00
In stock
SKU
HC02404-GL-MR_16526